Correlation Between Acarix AS and Enzymatica Publ

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Acarix AS and Enzymatica Publ at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acarix AS and Enzymatica Publ into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acarix AS and Enzymatica publ AB, you can compare the effects of market volatilities on Acarix AS and Enzymatica Publ and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acarix AS with a short position of Enzymatica Publ. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acarix AS and Enzymatica Publ.

Diversification Opportunities for Acarix AS and Enzymatica Publ

0.6
  Correlation Coefficient

Poor diversification

The 3 months correlation between Acarix and Enzymatica is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Acarix AS and Enzymatica publ AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enzymatica publ AB and Acarix AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acarix AS are associated (or correlated) with Enzymatica Publ. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enzymatica publ AB has no effect on the direction of Acarix AS i.e., Acarix AS and Enzymatica Publ go up and down completely randomly.

Pair Corralation between Acarix AS and Enzymatica Publ

Assuming the 90 days trading horizon Acarix AS is expected to generate 1.01 times more return on investment than Enzymatica Publ. However, Acarix AS is 1.01 times more volatile than Enzymatica publ AB. It trades about 0.0 of its potential returns per unit of risk. Enzymatica publ AB is currently generating about -0.09 per unit of risk. If you would invest  29.00  in Acarix AS on August 25, 2025 and sell it today you would lose (1.00) from holding Acarix AS or give up 3.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Acarix AS  vs.  Enzymatica publ AB

 Performance 
       Timeline  
Acarix AS 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Acarix AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Acarix AS is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.
Enzymatica publ AB 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Enzymatica publ AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Acarix AS and Enzymatica Publ Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Acarix AS and Enzymatica Publ

The main advantage of trading using opposite Acarix AS and Enzymatica Publ positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acarix AS position performs unexpectedly, Enzymatica Publ can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzymatica Publ will offset losses from the drop in Enzymatica Publ's long position.
The idea behind Acarix AS and Enzymatica publ AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account